Doctor Roni Nielsen
Aarhus University Hospital, Aarhus (Denmark)
Cardiovascular and metabolic effects of treatment with the ketone body 3-hydroxybutyrate in patients with chronic heart failure.
Event: ESC Congress 2020
Topic: Basic Science
Session: Metabolic Dysfunction in Heart Failure: Can We Harness the Power of Ketones?
The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients
Event: Heart Failure 2019
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Rapid Fire 2 - Biomarker: present and future
The ketone body 3-hydroxybutyrate increases cardiac output without affecting myocardial external efficiency
Event: ESC Congress 2018
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Skeletal muscle and energy metabolism: do they matter in heart failure?
The ketone body 3-hydroxybutyrate increases cardiac output and left ventricular contractile function in heart failure patients with reduced ejection fraction
Event: Heart Failure 2018
Topic: Treatment, Other
Session: Patient management - From oral treatment to transplant
Quantitative estimation of extravascular lung water volume and preload by dynamic 15O-H2O positron emission tomography
Event: Heart Failure 2018
Topic: Haemodynamics of Heart Failure
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
Effect of liraglutide on myocardial glucose uptake and blood flow in non-diabetic heart failure patients
Event: HEART FAILURE 2016
Topic: Metabolism / Diabetes mellitus
Session: Metabolism / Diabetes mellitus / Obesity
ESC 365 is supported by
